Company / EPS (Diluted)
Corbus Pharmaceuticals Holdings, Inc. EPS (Diluted) History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$11.15
FY2022
5-year range
-$11.15 / -$0.65
FY2018-FY2022
Trend
-685.2%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) changed -685% YoY in FY2022, a notable deviation from the 7-year average annual change of -146%.
Based on SEC 10-K filings.
-11.15 in FY2022.
Declined from $-1.12 to $-11.15 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Corbus Pharmaceuticals Holdings, Inc.'s eps (diluted) has declined for 5 consecutive years.
- In FY2022, eps (diluted) decreased 685.2% year-over-year.
- Peak eps (diluted) was recorded in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -12.48 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$11.15 | -685.2% |
| FY2021 | -$1.42 | -26.8% |
| FY2020 | -$1.12 | -14.3% |
| FY2019 | -$0.98 | -50.8% |
| FY2018 | -$0.65 | -132.1% |
| FY2017 | -$0.28 | +0.0% |
| FY2016 | -$0.28 | -115.4% |
| FY2015 | -$0.13 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026